期刊
MICROCIRCULATION
卷 18, 期 1, 页码 24-35出版社
WILEY
DOI: 10.1111/j.1549-8719.2010.00064.x
关键词
lymphatic muscle cells; substance P; neurokinin receptors; myosin light chain 20 phosphorylation; MAP kinase pathways
资金
- AHA [09POST2280005, R01 HL089784, RO1HL070308]
- NIH [RO1 HL080526, KO2 HL086650]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL086650, R01HL080526, R01HL089784, R01HL070308] Funding Source: NIH RePORTER
P>Objective: The aim of this study was to elucidate the molecular signaling mechanisms by which substance P (SP) modulates lymphatic muscle contraction and to determine whether SP stimulates both contractile as well as inflammatory pathways in the lymphatics. Methods: A rat mesenteric lymphatic muscle cell culture model (RMLMCs) and known specific pharmacological inhibitors were utilized to delineate SP-mediated signaling pathways in lymphatics. Results: We detected expression of neurokinin receptor 1 (NK1R) and neurokinin receptor 3 (NK3R) in RMLMCs. SP stimulation increased phosphorylation of myosin light chain 20 (MLC20) as well as p38 mitogen associated protein kinase (p38-MAPK) and extracellular signal regulated kinase (ERK1/2) indicating activation of both a contractile and a pro-inflammatory MAPK pathway. Pharmacological inhibition of both NK1R and NK3R significantly affected the downstream SP signaling. We further examined whether there was any crosstalk between the two pathways upon SP stimulation. Inhibition of ERK1/2 decreased levels of p-MLC20 after SP activation, in a PKC dependent manner, indicating a potential crosstalk between these two pathways. Conclusions: These data provide the first evidence that SP-mediated crosstalk between pro-inflammatory and contractile signaling mechanisms exists in the lymphatic system and may be an important bridge between lymphatic function modulation and inflammation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据